newsfilter
← Latest News
Business Wire·

Pathos AI Secures $237 Million in Series E Financing to Scale Agentic AI Drug Development Platform and Advance Oncology Pipeline

Funding follows rapid portfolio expansion and will power the initiation of a registrational study for AI-identified asset JSKN016 Pathos AI, Inc., a clinical-stage AI and technology company advancing its own